Moxonidine shortage

As of 2 Nov 2026, Moxonidine has a reported shortage in 2 of the 16 countries we track (Norway, Sweden), covering 2 products from 2 companies.

Is there a Moxonidine shortage?

Yes. As of 2 Nov 2026, Moxonidine is reported short in 2 of the 16 countries we track: Norway, Sweden. The earliest expected return is 11 Dec 2026 (Norway).

Countries2/16

Products2packs or presentations

Companies21 listed

Short since14 Sep 202649 days ago

Earliest return11 Dec 2026company estimate

Main reasonIncreased demand

Timeline

NorwaySweden

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries

Listed: Viatris VTRS · Nasdaq

Compared with similar medicines

ATC group C02AC · Imidazoline Receptor Agonists

Affected products

Country	Product	Company	Since	Expected back	Reason
NO	Physiotens 0,2 mg tablett, filmdrasjert, 98 stk blisterpakning	Viatris AS	14 Sep 2026	11 Dec 2026	Increased demand Uventet økt etterspørsel
SE	Moxonidin STADA 0,2 mg Blister, 100 tabletter anticipated	STADA Arzneimittel AG	3 Nov 2026	28 Feb 2027	Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Moxonidine shortage?

Yes. As of 2 Nov 2026, Moxonidine is reported short in 2 of the 16 countries we track: Norway, Sweden. The earliest expected return is 11 Dec 2026 (Norway).

When will Moxonidine be back in stock?

Companies expect supply back from 11 Dec 2026 in Norway; Norway: 11 Dec 2026; Sweden: 28 Feb 2027. These are company estimates reported to each authority.

Why is Moxonidine in short supply?

The most common reason reported is: increased demand. Reasons by product are listed in the table below.

Which companies have Moxonidine shortages?

Viatris, Stada.